(Q37106402)

18 August 2017

1 reference

title

Clinical features, differential diagnosis and treatment of autoimmune hepatitis in the elderly (English)

1 reference

18 August 2017

0 references

1 reference

Albert J Czaja

1

1 reference

PubMed ID

18331074

18 August 2017

language of work or name

1 reference

1 January 2008

1 reference

18 August 2017

1 reference

18 August 2017

25

1 reference

18 August 2017

3

1 reference

18 August 2017

219-239

1 reference

https://scigraph.springernature.com/pub.10.2165/00002512-200825030-00005

18 August 2017

0 references

cites work

Type I autoimmune hepatitis is primarily a disease of later life

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825030-00005

Changes in circulating B cells and immunoglobulin classes and subclasses in a healthy aged population

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825030-00005

Genetic distinctions between autoimmune hepatitis in Italy and North America

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825030-00005

Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825030-00005

Controlled Prospective Trial of Corticosteroid Therapy in Active Chronic Hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825030-00005

Mycophenolate mofetil for the treatment of autoimmune hepatitis in patients refractory to standard therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825030-00005

Budesonide induces complete remission in autoimmune hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825030-00005

Side effects of budesonide in liver cirrhosis due to chronic autoimmune hepatitis: influence of hepatic metabolism versus portosystemic shunts on a patient complicated with HCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.2165%2F00002512-200825030-00005

Promising treatment of autoimmune hepatitis with 6-thioguanine after adverse events on azathioprine

21 January 2018

1 reference

12 December 2020

Deflazacort for long-term maintenance of remission in type I autoimmune hepatitis.

1 reference

12 December 2020

Clinical significance of HLA DRB103-DRB104 in type 1 autoimmune hepatitis

1 reference

12 December 2020

Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared

1 reference

12 December 2020

Transplantation of anergic histoincompatible bone marrow allografts

1 reference

12 December 2020

Antibodies to conformational epitopes of soluble liver antigen define a severe form of autoimmune liver disease

1 reference

12 December 2020

1 reference

12 December 2020

Reciprocal change with age in antibody to extrinsic and intrinsic antigens.

1 reference

12 December 2020

Sustained remission after corticosteroid therapy of severe hepatitis B surface antigen-negative chronic active hepatitis

1 reference

12 December 2020

Thiopurine methyltransferase deficiency and azathioprine intolerance in autoimmune hepatitis

1 reference

12 December 2020

Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis

1 reference

12 December 2020

Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis

1 reference

12 December 2020

Clinical and HLA phenotypes of type 1 autoimmune hepatitis in North American patients outside DR3 and DR4

1 reference

12 December 2020

Extrahepatic malignancy following long-term immunosuppressive therapy of severe hepatitis B surface antigen-negative chronic active hepatitis

1 reference

12 December 2020

1 reference

12 December 2020

Successful treatment of autoimmune hepatitis and idiopathic thrombocytopenic purpura with the monoclonal antibody, rituximab: case report and review of literature

1 reference

12 December 2020

Autoimmune hepatitis in African Americans: presenting features and response to therapy

1 reference

12 December 2020

Complete resolution of inflammatory activity following corticosteroid treatment of HBsAg-negative chronic active hepatitis

1 reference

12 December 2020

Prognosis of histological cirrhosis in type 1 autoimmune hepatitis.

1 reference

12 December 2020

Liver biopsy interpretation for causes of late liver allograft dysfunction

1 reference

12 December 2020

Significance of HLA DR4 in type 1 autoimmune hepatitis

1 reference

12 December 2020

Thiopurine methyltransferase phenotype and genotype in relation to azathioprine therapy in autoimmune hepatitis

1 reference

12 December 2020

The significance of natural autoantibodies

1 reference

12 December 2020

Long-term follow-up after liver transplantation for autoimmune hepatitis: evidence of recurrence of primary disease

1 reference

12 December 2020

International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis

1 reference

12 December 2020

Immune senescence: mechanisms and clinical implications

1 reference

12 December 2020

Fulminant hepatic failure as the initial presentation of acute autoimmune hepatitis

1 reference

12 December 2020

Relationship between human leukocyte antigen-DRB1 and autoimmune hepatitis type I in Chinese patients.

1 reference

12 December 2020

Recurrent autoimmune hepatitis after orthotopic liver transplantation

1 reference

12 December 2020

Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis

1 reference

12 December 2020

Structural basis of specificity and degeneracy of T cell recognition: pluriallelic restriction of T cell responses to a peptide antigen involves both specific and promiscuous interactions between the T cell receptor, peptide, and HLA-DR.

1 reference

12 December 2020

Acute autoimmune hepatitis presenting with centrizonal liver disease: case report and review of the literature.

1 reference

12 December 2020

Autoimmune cholangitis within the spectrum of autoimmune liver disease

1 reference

12 December 2020

Failure of customary treatment in chronic active liver disease: causes and management

1 reference

12 December 2020

Clinical features of type 1 autoimmune hepatitis in elderly Italian patients

1 reference

12 December 2020

Autoimmune hepatitis in older patients.

1 reference

12 December 2020

The nature of unexplained chronic aminotransferase elevations of a mild to moderate degree in asymptomatic patients

1 reference

12 December 2020

Susceptibility to autoimmune chronic active hepatitis: human leukocyte antigens DR4 and A1-B8-DR3 are independent risk factors

1 reference

12 December 2020

Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis

1 reference

12 December 2020

Prevalence of autoimmune liver disease in Alaska Natives

1 reference

12 December 2020

Allelic basis for HLA-encoded susceptibility to type 1 autoimmune hepatitis

1 reference

12 December 2020

Frequency and significance of antibodies to asialoglycoprotein receptor in type 1 autoimmune hepatitis

1 reference

12 December 2020

Clinical distinctions and pathogenic implications of type 1 autoimmune hepatitis in Brazil and the United States.

1 reference

12 December 2020

Autoimmune chronic active hepatitis in postmenopausal women

1 reference

12 December 2020

Autoantibodies in autoimmune liver disease

1 reference

12 December 2020

Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses

1 reference

12 December 2020

Decreased fibrosis during corticosteroid therapy of autoimmune hepatitis

1 reference

12 December 2020

Transplant immunosuppressive agents in non-transplant chronic autoimmune hepatitis: the Canadian association for the study of liver (CASL) experience with mycophenolate mofetil and tacrolimus

1 reference

12 December 2020

Treatment strategies in autoimmune hepatitis

1 reference

12 December 2020

Oral budesonide for treatment of autoimmune chronic active hepatitis.

1 reference

12 December 2020

Hypothesis: The Aging Paradox and Autoimmune Disease

1 reference

12 December 2020

Diverse manifestations and evolving treatments of autoimmune hepatitis.

1 reference

12 December 2020

Frequency and significance of antibodies to actin in type 1 autoimmune hepatitis

1 reference

12 December 2020

Hepatic manifestations of autoimmune rheumatic diseases

1 reference

12 December 2020

Liver transplantation in patients over 60 and 65 years: an evaluation of long-term outcomes and survival

1 reference

12 December 2020

Current concepts in autoimmune hepatitis

1 reference

12 December 2020

Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis

1 reference

12 December 2020

Low-dose corticosteroid therapy after multiple relapses of severe HBsAg-negative chronic active hepatitis

1 reference

12 December 2020

Severe chronic active liver disease. Prognostic significance of initial morphologic patterns

1 reference

12 December 2020

Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis.

1 reference

12 December 2020

Response to steroids in de novo autoimmune hepatitis after liver transplantation

1 reference

12 December 2020

Azathioprine for long-term maintenance of remission in autoimmune hepatitis

1 reference

12 December 2020

Antibodies to soluble liver antigen/liver pancreas and HLA risk factors for type 1 autoimmune hepatitis

1 reference

12 December 2020

Distinctive clinical phenotype and treatment outcome of type 1 autoimmune hepatitis in the elderly

1 reference

12 December 2020

Clinicopathological features of acute-onset autoimmune hepatitis

1 reference

12 December 2020

Tacrolimus: a potential new treatment for autoimmune chronic active hepatitis: results of an open-label preliminary trial

1 reference

12 December 2020

Successful treatment of refractory type 1 autoimmune hepatitis with methotrexate

1 reference

12 December 2020

Clinical characteristics of autoimmune hepatitis in older aged patients

1 reference

12 December 2020

Methyldopa Hepatitis. A report of six cases and review of the literature

1 reference

12 December 2020

Genetic distinctions between types 1 and 2 autoimmune hepatitis

1 reference

12 December 2020

Liver transplantation in the United States from 1987-1998: updated results from the Pitt-UNOS Liver Transplant Registry

1 reference

12 December 2020

Efficacy and safety of retreatment with anti-tumor necrosis factor antibody (infliximab) to maintain remission in Crohn's disease.

1 reference

12 December 2020

Autoimmune hepatitis in the elderly

1 reference

12 December 2020

Efficacy of ursodeoxycholic acid in Japanese patients with type 1 autoimmune hepatitis

1 reference

12 December 2020

Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis

1 reference

12 December 2020

Genetic predispositions for the immunological features of chronic active hepatitis

1 reference

12 December 2020

Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis

1 reference

12 December 2020

An unusual form of autoimmune hepatitis in young Somalian men.

1 reference

12 December 2020

Autoimmune hepatitis (AIH) in the elderly: a systematic retrospective analysis of a large group of consecutive patients with definite AIH followed at a tertiary referral centre

1 reference

12 December 2020

Frequency and nature of the variant syndromes of autoimmune liver disease

1 reference

12 December 2020

Acute-onset autoimmune hepatitis resembling acute hepatitis: a case report and review of reported cases.

1 reference

12 December 2020

Autoimmune hepatitis: effect of symptoms and cirrhosis on natural history and outcome.

1 reference

12 December 2020

Recent-onset autoimmune hepatitis. Biopsy findings and clinical correlations

1 reference

12 December 2020

Improving the end point of corticosteroid therapy in type 1 autoimmune hepatitis to reduce the frequency of relapse

1 reference

12 December 2020

Diclofenac-associated hepatotoxicity

1 reference

12 December 2020

Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders

1 reference

12 December 2020

The effect of infections on susceptibility to autoimmune and allergic diseases

1 reference

12 December 2020

The HLA dictionary 2001: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR, and -DQ antigens.

1 reference

12 December 2020

Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis

1 reference

12 December 2020

Study of immune reactivity of minocycline-induced chronic active hepatitis

1 reference

12 December 2020

Mycophenolate mofetil for maintenance of remission in autoimmune hepatitis in patients resistant to or intolerant of azathioprine.

1 reference

12 December 2020

MHC class II sequences of susceptibility and protection in Mexicans with autoimmune hepatitis

1 reference

12 December 2020

Autoimmune hepatitis in the elderly: what is the difference?

1 reference

12 December 2020

Sustained remission after corticosteroid therapy for type 1 autoimmune hepatitis: a retrospective analysis

1 reference

12 December 2020

Diagnosis and treatment of autoimmune hepatitis

1 reference

12 December 2020

Characteristics of autoimmune hepatitis in patients who are not of European Caucasoid ethnic origin

1 reference

12 December 2020

High prevalence of celiac disease in autoimmune hepatitis detected by anti-tissue tranglutaminase autoantibodies.

1 reference

12 December 2020

HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis

1 reference

12 December 2020

The prognosis of chronic active hepatitis without cirrhosis in relation to bridging necrosis

1 reference

12 December 2020

Antibodies to filamentous actin (F-actin) in type 1 autoimmune hepatitis

1 reference

12 December 2020

Budesonide in previously untreated autoimmune hepatitis.

1 reference

12 December 2020

Chronic active autoimmune hepatitis in children. Strong association with a particular HLA-DR6 (DRB1*1301) haplotype

1 reference

12 December 2020

Influence of aetiology, clinical and histological features on survival in chronic active hepatitis: an analysis of 204 patients.

1 reference

12 December 2020

Structure and function of natural antibodies.

1 reference

12 December 2020

Antibodies to liver-specific protein predict outcome of treatment withdrawal in autoimmune chronic active hepatitis

1 reference

12 December 2020

Empiric therapy of autoimmune hepatitis with mycophenolate mofetil: comparison with conventional treatment for refractory disease

1 reference

12 December 2020

Cyclophosphamide as alternative immunosuppressive therapy for autoimmune hepatitis--report of three cases

1 reference

12 December 2020

Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults.

1 reference

12 December 2020

Suppression of murine experimental autoimmune hepatitis by T-cell vaccination or immunosuppression.

1 reference

12 December 2020

Autoimmune hepatitis with incidental histologic features of bile duct injury.

1 reference

12 December 2020

Frequency and significance of antibodies to soluble liver antigen/liver pancreas in variant autoimmune hepatitis

1 reference

12 December 2020

Autoimmunity in a rural community

1 reference

12 December 2020

Utility of thiopurine methyltransferase genotyping and phenotyping, and measurement of azathioprine metabolites in the management of patients with autoimmune hepatitis

1 reference

12 December 2020

1 reference

12 December 2020

The validity and importance of subtypes in autoimmune hepatitis: a point of view

1 reference

12 December 2020

Prognosis of symptomatic versus asymptomatic autoimmune hepatitis: a study of 68 patients

1 reference

12 December 2020

Isoniazid-associated hepatitis in 114 patients

1 reference

12 December 2020

Cyclosporin A is a promising alternative to corticosteroids in autoimmune hepatitis

1 reference

12 December 2020

Liver Disease Caused by Propylthiouracil

1 reference

12 December 2020

Chronic active hepatitis and severe hepatic necrosis associated with nitrofurantoin

1 reference

12 December 2020

LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase

1 reference

12 December 2020

Exacerbated autoimmune hepatitis successfully treated with leukocytapheresis and bilirubin adsorption therapy

1 reference

12 December 2020

Pathogenesis of autoimmune hepatitis

1 reference

12 December 2020

Efficacy of tacrolimus in the treatment of steroid refractory autoimmune hepatitis

1 reference

12 December 2020

Failure of budesonide in a pilot study of treatment-dependent autoimmune hepatitis

1 reference

12 December 2020

Allograft rejection after liver transplantation for autoimmune liver diseases

1 reference

12 December 2020

Positive selection of natural autoreactive B cells

1 reference

12 December 2020

Autoimmune hepatitis with centrilobular necrosis

1 reference

12 December 2020

Efficacy of intravenous immunoglobulin therapy in a case of autoimmune-mediated chronic active hepatitis

1 reference

12 December 2020

Association of autoimmune hepatitis with HLA-Bw54 and DR4 in Japanese patients

1 reference

12 December 2020

Evolving concepts in the diagnosis, pathogenesis and treatment of autoimmune hepatitis

1 reference

12 December 2020

T-cell function in aging: mechanisms of decline

1 reference

12 December 2020

Prognosis of corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis in postmenopausal women: a retrospective analysis

1 reference

12 December 2020

The nature and prognostic implications of autoimmune hepatitis with an acute presentation

1 reference

12 December 2020

Factors predicting relapse and poor outcome in type I autoimmune hepatitis: role of cirrhosis development, patterns of transaminases during remission and plasma cell activity in the liver biopsy

1 reference

12 December 2020

Oral tolerance in the treatment of inflammatory autoimmune diseases

1 reference

12 December 2020

Immune phenotype of chronic liver disease.

1 reference

12 December 2020

Clinical features and prognosis of severe chronic active liver disease (CALD) after corticosteroid-induced remission

1 reference

12 December 2020

Diagnosis and treatment of autoimmune hepatitis at age 65 and older

1 reference

12 December 2020

HLA class II molecules and autoimmune hepatitis susceptibility in Japanese patients

1 reference

12 December 2020

Genetic heterogeneity in susceptibility to autoimmune hepatitis types 1 and 2

1 reference

12 December 2020

Controlled trial of prednisone and azathioprine in active chronic hepatitis

1 reference

12 December 2020

Manifestations of nonsuppurative cholangitis in chronic hepatobiliary diseases: morphologic spectrum, clinical correlations and terminology

1 reference

12 December 2020

Relapse following treatment withdrawal in patients with autoimmune chronic active hepatitis

1 reference

12 December 2020

Persistent normalization of serum alanine aminotransferase levels improves the prognosis of type 1 autoimmune hepatitis

1 reference

12 December 2020

Prednisone for chronic active hepatitis: pharmacokinetics and serum binding in patients with chronic active hepatitis and steroid major side effects

1 reference

12 December 2020

Understanding the pathogenesis of autoimmune hepatitis

1 reference

12 December 2020

Clinical, biochemical, and histological remission of severe chronic active liver disease: a controlled study of treatments and early prognosis.

1 reference

12 December 2020

Altered major histocompatibility complex-restricted antigen recognition by T cells from elderly humans

1 reference

12 December 2020

Evolving new therapies of autoimmune hepatitis

1 reference

12 December 2020

Treatment of autoimmune hepatitis

1 reference

12 December 2020

Gender effects and synergisms with histocompatibility leukocyte antigens in type 1 autoimmune hepatitis

1 reference

12 December 2020

10.2165/00002512-200825030-00005

Identifiers

DOI

1 reference

18 August 2017

1 reference

PubMed ID

18331074